Trxade Group, Inc. (MEDS)
| Market Cap | 42.58M |
| Revenue (ttm) | 17.97M |
| Net Income (ttm) | -3.37M |
| Shares Out | 8.09M |
| EPS (ttm) | -0.43 |
| PE Ratio | n/a |
| Forward PE | 21.83 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 16 |
| Last Price | $4.57 |
| Previous Close | $5.01 |
| Change ($) | -0.44 |
| Change (%) | -8.78% |
| Day's Open | 4.84 |
| Day's Range | 4.41 - 5.15 |
| Day's Volume | 908,638 |
| 52-Week Range | 3.10 - 10.82 |
Ramped up Covid-19 vaccinations and easing restrictions across the globe are leading to strength in the travel sector.
Today, MEDS stock is soaring after the company announced the launch of an application designed to be a Covid-19 passport. The post MEDS Stock: The Huge Covid-19 News Lifting Trxade Health Today appeared...
Trxade Health (NASDAQ: MEDS) is a health services IT company that focuses on digitalizing the retail pharmacy experience. While the company has expertise in optimizing drug procurements and patient enga...
Trxade Health Inc (NASDAQ:MEDS) shares are trading higher by 103.4% at $8.30 after the company announced the launch of its MedCheks health passport app for iOS devices. Trxade Health is a health service...
TAMPA, FL / ACCESSWIRE / June 1, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescri...
CEO Suren Ajjarapu to Present Wednesday, June 9th, 2021 TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE HEALTH, INC. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmac...
TAMPA, FL / ACCESSWIRE / May 28, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescrip...
TRxADE Telehealth Subsidiary Bonum Health to Provide Affordable Telemedicine Services to Patients at Leading Grocery Store Chain TAMPA, FL / ACCESSWIRE / May 6, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), ...
TRxADE Group Launches GPO+, a Next-Generation Group Purchasing Option for Drug Buying Groups TAMPA, FL / ACCESSWIRE / May 4, 2021 / TRxADE Group, Inc. (NASDAQ:MEDS), a health services IT company focused...
Health Passport Subsidiary Medcheks has Launched Next-Generation, Scalable Reopening Tools to Enable Expedited Post-COVID-19 Reopening to Align with Rapidly Evolving Global Mandates TAMPA, FL / ACCESSWI...
Shares of Trxade Group (NASDAQ:MEDS) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 500.00% over the past year to ($0.08), which misse...
First Quarter Revenues Increased 39% to $3.1 Million
TAMPA, FL / ACCESSWIRE / April 12, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the presc...
CEO Suren Ajjarapu to Present Wednesday, April 21st, 2021 TAMPA, FL / ACCESSWIRE / April 9, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a health services IT company focused on digitalizing the retail pharm...
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT Platform
TAMPA, FL / ACCESSWIRE / March 15, 2021 / Trxade Group, Inc. (NASDAQ:MEDS) , is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the pr...
TAMPA, FL / ACCESSWIRE / March 5, 2021 / Trxade Group, Inc. (NASDAQ:MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, today announced t...
TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equ...
Trxade Group Inc. (NASDAQ: MEDS) shares jumped on Tuesday after the company announced that it entered into a definitive agreement with Amazon.com Inc.
Shares of Trxade Group Inc. soared 56% in active trading to pace all of the premarket's gainers Tuesday, after the online platform for pharmaceutical purchases announced a market program agreement with ...
About MEDS
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TR... [Read more...]
| Industry Pharmaceutical Retailers | IPO Date Feb 13, 2020 |
| Stock Exchange NASDAQ | Ticker Symbol MEDS |
Financial Performance
In 2020, Trxade Group's revenue was $17.12 million, an increase of 130.26% compared to the previous year's $7.44 million. Losses were -$2.54 million, 791.6% more than in 2019.
Analyst Forecasts
According to 3 analysts, the average rating for Trxade Group stock is "Buy." The 12-month stock price forecast is 9.25, which is an increase of 102.41% from the latest price.